The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the 99mTc …

CA Tokin, FO Cope, WL Metz, MS Blue… - Clinical & experimental …, 2012 - Springer
Sentinel lymph node (SLN) mapping is common, however question remains as to what the
ideal imaging agent is and how such an agent might provide reliable and stable localization …

Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment

…, A Romano, A Paun, MM Chaves, FO Cope… - Journal of Experimental …, 2018 - rupress.org
The origin and functional specialization of dermal macrophages in cutaneous infections
have been little studied. In this paper, we show that a strain of Leishmania major (L. major …

[HTML][HTML] γ-Tilmanocept, a new radiopharmaceutical tracer for cancer sentinel lymph nodes, binds to the mannose receptor (CD206)

AK Azad, MVS Rajaram, WL Metz, FO Cope… - The Journal of …, 2015 - journals.aai.org
γ-Tilmanocept (99m Tc-labeled-tilmanocept or [99m Tc]-tilmanocept) is the first mannose-containing,
receptor-directed, radiolabeled tracer for the highly sensitive imaging of sentinel …

A Phase 2 Study of 99mTc-Tilmanocept in the Detection of Sentinel Lymph Nodes in Melanoma and Breast Cancer

…, CR Scoggins, WL Rich Metz, FO Cope… - Annals of surgical …, 2011 - Springer
Background Several 99m Tc-labeled agents that are not approved by the US Food and
Drug Administration are used for lymphatic mapping. A new low-molecular-weight mannose …

Discovery of anticancer agents of diverse natural origin

…, GD Vite, S Emanuel, D Jarjoura, FO Cope - Pure and Applied …, 2009 - degruyter.com
A collaborative multidisciplinary research project is described in which new natural product
anticancer drug leads are obtained from a diverse group of organisms, constituted by tropical …

Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence

M Sanchez-Cespedes, M Esteller, K Hibi, FO Cope… - Clinical Cancer …, 1999 - AACR
Disseminated disease, especially to the liver, constitutes the major risk of recurrence for
colorectal cancer patients. However, successful resection can still be achieved in 25–35% of …

[HTML][HTML] The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach

FO Cope, B Abbruzzese, J Sanders, W Metz… - Nuclear medicine and …, 2016 - Elsevier
In considering the challenges of approaches to clinical imaging, we are faced with choices
that sometimes are impacted by rather dogmatic notions about what is a better or worse …

Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV-Infected Individuals

…, B Foldyna, L Stone, A Martin, F Cope… - The Journal of …, 2017 - academic.oup.com
Background. The ability to noninvasively assess arterial CD206 + macrophages may lead to
improved understanding of human immunodeficiency virus (HIV)–associated …

Long-term effects of early nutritional support with new enterotropic peptide-based formula vs. standard enteral formula in HIV-infected patients: randomized …

…, BC Abbruzzese, MA McCamish, FO Cope - … Burbank, Los Angeles …, 1993 - europepmc.org
Cope FO … standard enteral formula in HIV-infected patients: randomised prospective
trial Chlebowski RT, Beall G, Grovenor M, Lillington L, Weintraub N, Ambler C, Richards EW …

De novo lipogenesis predicts short-term body-composition response by bioelectrical impedance analysis to oral nutritional supplements in HIV-associated wasting

…, RA Neese, M Chan, JP Cello, FO Cope… - The American journal of …, 1998 - Elsevier
We studied the effects of enteral supplements on protein and energy intakes, body
composition, energy expenditure, and gastrointestinal histology in 49 subjects with human …